All 57 CANC (Tema Oncology ETF) Holdings
There are 57 CANC holdings. Top 10 companies weight: 42.12%.
Total Market Cap: $2.99T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (57 stocks) | +16.88% | 29.64 | 19.09 | 0.39 | +17.43% | +20.93% | 0.47 | ||||||||||
1 | RVMD | Revolution Medicines Inc Ordinary Shares | 7.31% | $151.31 | $31B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +22.61% | $186 | +38.07% | 1.07 |
2 | LLY | Eli Lilly And Co | 4.25% | $1,065.12 | $970B | Drug Manufacturers - General | Healthcare | +29.14% | 45.43 | 29.85 | 0.18 | N/A | N/A | 71 | +14.08% | $1.22K | +40.67% | 0.71 |
3 | IMNM | Immunome Inc Ordinary Shares | 4.21% | $19.34 | $2.50B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +82.83% | $35 | -0.06% | 1.69 |
4 | COGT | Cogent Biosciences Inc | 4.08% | $32.76 | $5.89B | Biotechnology | Healthcare | -15.32% | N/A | N/A | N/A | N/A | N/A | 75 | +65.60% | $54 | +32.60% | 1.74 |
5 | RHHBY | Roche Holding Ag Adr | 4.07% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | n/a | Novartis Ag Registered Shares | 4.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | CELC | Celcuity Inc | 3.93% | $91.42 | $6.48B | Biotechnology | Healthcare | +36.83% | N/A | N/A | N/A | N/A | N/A | 77 | +84.86% | $169 | +29.16% | 1.06 |
8 | AZN:XLON | Astrazeneca Plc | 3.50% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | MRK | Merck & Co Inc | 3.43% | $115.70 | $297B | Drug Manufacturers - General | Healthcare | +4.39% | 27.45 | 22.78 | 5.59 | N/A | N/A | 69 | +12.13% | $130 | +12.86% | 0.32 |
10 | BMY | Bristol-myers Squibb Co | 3.34% | $54.46 | $117B | Drug Manufacturers - General | Healthcare | +5.08% | 13.54 | 9.06 | 183.93 | N/A | N/A | 61 | +15.83% | $63 | +0.55% | 0.26 |
11 | NUVL | Nuvalent Inc Class A | 3.15% | $91.35 | $8.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +58.20% | $145 | 0.00% | 1.03 |
12 | LEGN | Legend Biotech Corp Adr | 2.94% | $36.28 | $5.26B | Biotechnology | Healthcare | -13.49% | N/A | 181.82 | N/A | N/A | N/A | 80 | +52.67% | $55 | -1.81% | 0.54 |
13 | GMAB | Genmab As Adr | 2.87% | $23.85 | $17B | Biotechnology | Healthcare | -12.66% | 40.20 | 15.53 | 1.75 | N/A | N/A | N/A | N/A | N/A | -10.11% | N/A |
14 | ABBV | Abbvie Inc | 2.70% | $215.41 | $381B | Drug Manufacturers - General | Healthcare | -19.65% | 122.69 | 14.95 | 0.59 | N/A | N/A | 75 | +17.40% | $253 | +18.31% | 0.32 |
15 | BBIO | Bridgebio Pharma Inc | 2.63% | $63.88 | $13B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 80 | +60.69% | $103 | +1.67% | 1.09 |
16 | CGON | Cg Oncology Inc | 2.56% | $55.53 | $5.35B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +62.60% | $90 | 0.00% | 1.46 |
17 | JNJ | Johnson & Johnson | 2.55% | $222.89 | $557B | Drug Manufacturers - General | Healthcare | +11.59% | 20.68 | 19.49 | 3.01 | N/A | N/A | 68 | +13.45% | $253 | +9.09% | 0.01 |
18 | ZLAB | Zai Lab Ltd Adr Repr 1 Shs | 2.49% | $17.15 | $2.08B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +96.97% | $34 | -37.25% | 0.90 |
19 | EXEL | Exelixis Inc | 2.45% | $48.54 | $13B | Biotechnology | Healthcare | +72.24% | 15.79 | 15.92 | 0.41 | N/A | N/A | 61 | +2.29% | $50 | +16.95% | 0.55 |
20 | IDYA | Ideaya Biosciences Inc | 2.10% | $27.87 | $2.57B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +85.47% | $52 | +6.44% | 1.11 |
21 | AMGN | Amgen Inc | 2.04% | $328.26 | $181B | Drug Manufacturers - General | Healthcare | +3.49% | 23.21 | 14.79 | 0.75 | N/A | N/A | 60 | +7.30% | $352 | +10.27% | 0.48 |
22 | ONC | Beone Medicines Ltd Adr | 1.95% | $274.69 | $35B | Biotechnology | Healthcare | N/A | 67.03 | 46.73 | N/A | N/A | N/A | 81 | +49.81% | $412 | -4.72% | 0.53 |
23 | ZYME | Zymeworks Inc Registered Shs | 1.62% | $24.11 | $1.81B | Biotechnology | Healthcare | N/A | N/A | 24.57 | N/A | N/A | N/A | 78 | +66.53% | $40 | -5.09% | 0.84 |
24 | FXFXX | First American Treasury Obligs X | 1.47% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
25 | ANAB | Anaptysbio Inc | 1.25% | $51.26 | $1.67B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 79 | +64.75% | $84 | +26.40% | 0.81 |
26 | RCUS | Arcus Biosciences Inc | 1.24% | $24.47 | $3.01B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +42.30% | $35 | -0.26% | 1.50 |
27 | RLAY | Relay Therapeutics Inc Ordinary Shares | 1.21% | $15.70 | $2.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +54.46% | $24 | -13.31% | 1.84 |
28 | ERAS | Erasca Inc | 1.20% | $13.48 | $3.88B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +50.59% | $20 | 0.00% | 1.30 |
29 | HALO | Halozyme Therapeutics Inc | 1.20% | $66.28 | $8.14B | Biotechnology | Healthcare | +20.06% | 23.20 | 9.43 | N/A | N/A | N/A | 69 | +26.58% | $84 | +11.28% | 0.64 |
30 | ELVN | Enliven Therapeutics Inc | 1.19% | $35.52 | $2.52B | Biotechnology | Healthcare | -7.13% | N/A | N/A | N/A | N/A | N/A | 75 | +60.47% | $57 | +1.63% | 1.23 |
31 | SMMT | Summit Therapeutics Inc Ordinary Shares | 1.18% | $14.86 | $14B | Biotechnology | Healthcare | N/A | N/A | 3.72 | N/A | N/A | N/A | 60 | +92.87% | $29 | +13.85% | 1.80 |
32 | GILD | Gilead Sciences Inc | 1.11% | $127.57 | $166B | Drug Manufacturers - General | Healthcare | +98.59% | 18.01 | 15.22 | 0.33 | N/A | N/A | N/A | N/A | N/A | +18.23% | N/A |
33 | IMTX | Immatics Nv Ordinary Shares | 1.09% | $10.04 | $1.53B | Biotechnology | Healthcare | -14.98% | N/A | N/A | N/A | N/A | N/A | 75 | +86.95% | $19 | -2.98% | 1.31 |
34 | NUVB | Nuvation Bio Inc Ordinary Shares Class A | 1.00% | $4.90 | $1.64B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +151.63% | $12 | -18.26% | 1.49 |
35 | CRVS | Corvus Pharmaceuticals Inc | 0.99% | $11.69 | $1.09B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +34.16% | N/A |
36 | URGN | Urogen Pharma Ltd | 0.98% | $26.54 | $1.43B | Biotechnology | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 75 | +38.96% | $37 | +7.68% | 1.18 |
37 | REGN | Regeneron Pharmaceuticals Inc | 0.87% | $602.92 | $65B | Biotechnology | Healthcare | +20.31% | 14.98 | 13.39 | 83.17 | N/A | N/A | 72 | +38.21% | $833 | +3.75% | 0.64 |
38 | INBX | Inhibrx Biosciences Inc | 0.74% | $93.63 | $1.50B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 62 | +196.38% | $278 | 0.00% | 1.39 |
39 | GH | Guardant Health Inc | 0.73% | $130.17 | $17B | Diagnostics & Research | Healthcare | +1.05% | N/A | N/A | N/A | N/A | N/A | 75 | +0.82% | $131 | +2.00% | 1.22 |
40 | n/a | Chugai Pharmaceutical Co Ltd | 0.71% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
41 | OLMA | Olema Pharmaceuticals Inc Ordinary Shares | 0.67% | $10.69 | $1.13B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +291.21% | $42 | -17.30% | 0.70 |
42 | IOVA | Iovance Biotherapeutics Inc | 0.62% | $4.10 | $1.91B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +114.63% | $8.80 | -25.12% | 1.66 |
43 | NTRA | Natera Inc | 0.60% | $212.73 | $29B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +22.64% | $261 | +17.58% | 1.34 |
44 | TRAX | First Tracks Biotherapeutics Inc | 0.59% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
45 | SNDX | Syndax Pharmaceuticals Inc | 0.58% | $18.39 | $1.74B | Biotechnology | Healthcare | +12.13% | N/A | N/A | N/A | N/A | N/A | 78 | +113.43% | $39 | +0.53% | 1.07 |
46 | CGEM | Cullinan Therapeutics Inc | 0.55% | $15.34 | $954M | Biotechnology | Healthcare | N/A | N/A | 6.74 | N/A | N/A | N/A | 77 | +105.02% | $31 | -12.41% | 1.05 |
47 | CTMX | Cytomx Therapeutics Inc | 0.55% | $3.16 | $675M | Biotechnology | Healthcare | N/A | 25.70 | 14.20 | 0.79 | N/A | N/A | 83 | +293.67% | $12 | -14.21% | 2.03 |
48 | ARVN | Arvinas Inc | 0.52% | $8 | $571M | Biotechnology | Healthcare | +1.07% | N/A | 17.86 | N/A | N/A | N/A | 64 | +87.50% | $15 | -34.97% | 1.13 |
49 | HCM | Hutchmed (china) Ltd Adr | 0.51% | $11.52 | $2.50B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 5.36 | 43.67 | N/A | N/A | N/A | 71 | +98.26% | $23 | -17.59% | 0.80 |
50 | IMCR | Immunocore Holdings Plc Adr | 0.50% | $29.56 | $1.45B | Biotechnology | Healthcare | N/A | N/A | 196.08 | N/A | N/A | N/A | 70 | +114.78% | $63 | -6.08% | 0.72 |
CANC (Tema Oncology ETF) Sector Allocation
HEALTHCARE
80.40%MATERIALS
3.50%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%